TABLE 3.
Contribution of CYP1A2 to caffeine systemic clearance calculated from published mouse studies The difference between caffeine systemic clearance in the defined mouse strain and that in the Cyp1a KO mouse line was divided by the value of the systemic clearance in the defined mouse strain and then multiplied by 100% to obtain the contribution of CYP1A2. The clearance value measured in CYP1A2−/− mice was used to calculate CYP1A2 contribution to caffeine systemic clearance in C57BL/6N mice reported by Buters et al. (1996).
Mouse Line | Dose | Route | Clearance | Reference | CYP1A2 Contribution |
---|---|---|---|---|---|
mg/kg | ml/(h*kg) | % | |||
CYP1A2−/− | 2 | i.p. | 276 | Buters et al., 1996 | 0 |
C57BL/6N | 2 | i.p. | 2268 | Buters et al., 1996 | 88 |
Cyp1a KO | 5 | PO | 286 | This study | 0 |
C57BL/6J | 5 | PO | 905 | This study | 68 |
hCYP1A1/1A2 | 5 | PO | 614 | This study | 53 |
C57BL/6J | 5 | PO | 472a | Li et al., 2017 | 39 |
Swiss | 20 | PO | 311b | Samojlik et al., 2016 | 8 |
Swiss | 20 | i.p. | 398b | Samojlik et al., 2016 | 28 |
C57BL/6J | 5 | PO | 726 | Scheer et al., 2014 | 61 |
CD-COBS | 1 | i.v. | 732 | Walton et al., 2001 | 61 |
CD-1 | 20 | i.p. | 640 | Kaplan et al., 1990 | 55 |
CD-1 | 40 | i.p. | 380 | Kaplan et al., 1990 | 25 |
PO, per os (oral gavage).
As it was not clear if the AUC reported in the paper was an AUCinf, caffeine clearance was calculated from the C57BL/6J mean pharmacokinetic profile presented in Fig. 2 in the publication (Li et al., 2017).
Clearance was calculated by dividing dose by AUCinf.